Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: April 9, 2025

  • Open
    41.06
  • High
    43.91
  • Low
    39.60
  • Close
    42.57
  • Volume
    1,868,880

Financial ratios

Mar 31, 2024